Bovine spongiform encephalopathy, variant CJD, and blood transfusion: Beefer madness?

Transfusion

Volumn 44, Issue 5, 2004, Pages 628-630

  Dodd, Roger Y ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; CHRONIC WASTING DISEASE; COGNITION; CREUTZFELDT JAKOB DISEASE; DEER; DISEASE TRANSMISSION; EDITORIAL; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; FOOD CHAIN; HEALTH CARE POLICY; MASS SCREENING; MEDICAL DECISION MAKING; PRION; QUESTIONNAIRE; RED DEER; REGISTER; RISK FACTOR; SAFETY; SEVERE ACUTE RESPIRATORY SYNDROME; UNITED KINGDOM; UNITED STATES; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

ANIMALS; BLOOD DONORS; BLOOD TRANSFUSION; CATTLE; CREUTZFELDT-JAKOB SYNDROME; ENCEPHALOPATHY, BOVINE SPONGIFORM; HUMANS;

EID: 2342660650     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2004.44501.x     Document Type: Editorial

References (13)

1. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417-21.
2. News release: expanded "mad cow" safeguards announced to strengthen existing firewalls against BSE transmission (Internet). Washington (DC): U.S. Department of Health and Human Services, FDA Press; 2004 [last revised 2004 Jan 26]. Available from: http://www.hhs.gov/news/press/2004pres/20040126.html
3. Ault A. Blood transfusion suspected in new mad cow case in Britain. New York Times 2004 Jan 28;Sect. A:15.
4. Murphy EL, Connor D, McEvoy P, et al. Estimating blood donor loss due to the vCJD travel deferral. Transfusion 2004;44:645-50.
5. Whyte G. Quantitating donor behaviour to model the effect of changes in donor management on sufficiency in the blood service. Vox Sang 1999;76:209-15.
6. Schreiber GB, Sanches AM, Garratty G, et al. Mammalian brain consumption by US blood donors-brains today, deferred tomorrow? Transfusion 2004;44:667-74.
7. Bird SM. Recipients of blood or blood products "at vCJD risk." BMJ 2004;328:118-9.
8. Williams AE, Thomson RA, Schreiber GB, et al. Estimates of infectious disease risk factors in US blood donors. JAMA 1997;277:967-72.
9. Cervenakova L, Yakovleva O, McKenzie C, et al. Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy. Transfusion 2003;43:1687-94.
10. Dodd RY. Comment: dilemmas of dementia. J Clin Ethics 2001;12:141-2.
11. Reesink H, Engelfriet CP, Muylle L, et al. Future counseling of donors and recipients of blood products concerning prion-related diseases. Vox Sang 2003;85:126-48.
12. McCullough J, Anderson D, Brookie D, et al. Consensus conference on variant CJD screening of blood donors: report of the panel. Transfusion 2004;44:675-83.
13. Erdtmann R, Sivitz L, editors. Advancing prion science: guidance for the National Prion Research Program. Washington (DC): National Academies Press; 2004.